Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ENZYMES, CYTOCHROME P450' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 168 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bauman, JL
      The role of pharmacokinetics, drug interactions and pharmacogenetics in the acquired long QT syndrome

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    2. Schmeiser, HH; Gminski, R; Mersch-Sundermann, V
      Evaluation of health risks caused by musk ketone

      INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH
    3. Downs, CA; Fauth, JE; Woodley, CM
      Assessing the health of grass shrimp (Palaeomonetes pugio) exposed to natural and anthropogenic stressors: A molecular biomarker system

      MARINE BIOTECHNOLOGY
    4. Masimirembwa, CM; Thompson, R; Andersson, TB
      In vitro high throughput screening of compounds for favorable metabolic properties in drug discovery

      COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
    5. Guengerich, FP
      Forging the links between metabolism and carcinogenesis

      MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
    6. Oda, Y; Aryal, P; Terashita, T; Gillam, EMJ; Guengerich, FP; Shimada, T
      Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    7. Celenza, JL
      Metabolism of tyrosine and tryptophan - new genes for old pathways

      CURRENT OPINION IN PLANT BIOLOGY
    8. Bofinger, DP; Feng, L; Chi, LH; Love, J; Stephen, FD; Sutter, TR; Osteen, KG; Costich, TG; Batt, RE; Koury, ST; Olson, JR
      Effect of TCDD exposure on CYP1A1 and CYP1B1 expression in explant cultures of human endometrium

      TOXICOLOGICAL SCIENCES
    9. Kroll, DJ; Shaw, HS; Wall, ME; Oberlies, NH
      Variability in St. John's wort formulations is an important consideration

      ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE
    10. Frisbee, JC; Roman, RJ; Falck, JR; Krishna, M; Lombard, JH
      20-HETE contributes to myogenic activation of skeletal muscle resistance arteries in Brown Norway and Sprague-Dawley rats

      MICROCIRCULATION
    11. Kuehl, P; Zhang, J; Lin, Y; Lamba, J; Assem, M; Schuetz, J; Watkins, PB; Daly, A; Wrighton, SA; Hall, SD; Maurel, P; Relling, M; Brimer, C; Yasuda, K; Venkataramanan, R; Strom, S; Thummel, K; Boguski, MS; Schuetz, E
      Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

      NATURE GENETICS
    12. Frisbee, JC; Roman, RJ; Krishna, UM; Falck, JR; Lombard, JH
      Relative contributions of cyclooxygenase- and cytochrome p450 omega-hydroxylase-dependent pathways to hypoxic dilation of skeletal muscle resistance arteries

      JOURNAL OF VASCULAR RESEARCH
    13. Chen, S; Andreasson, E
      Update on glucosinolate metabolism and transport

      PLANT PHYSIOLOGY AND BIOCHEMISTRY
    14. Testai, E
      The drug-metabolizing enzymatic system and the experimental tools used forin vitro toxicology for metabolic studies

      CELL BIOLOGY AND TOXICOLOGY
    15. Helmberg, A
      DNA-microarrays: novel techniques to study aging and guide gerontologic medicine

      EXPERIMENTAL GERONTOLOGY
    16. Bonnabry, P; Sievering, J; Leemann, T; Dayer, P
      Quantitative drug interactions prediction system (Q-DIPS) - A dynamic computer-based method to assist in the choice of clinically relevant in vivo studies

      CLINICAL PHARMACOKINETICS
    17. Hyland, R; Roe, EGH; Jones, BC; Smith, DA
      Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    18. Lee, KJ; You, HJ; Park, SJ; Kim, YS; Chung, YC; Jeong, TC; Jeong, HG
      Hepatoprotective effects of Platycodon grandiflorum on acetaminophen-induced liver damage in mice

      CANCER LETTERS
    19. Ozdemir, V; Kalow, W; Posner, P; Collins, EJ; Kennedy, JL; Tang, BK; Albers, LJ; Reist, C; Roy, R; Walkes, W; Afra, P
      CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite norclozapine steady-state concentration in patients with schizophrenia

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    20. Mori, Y; Koide, A; Fuwa, K; Kobayashi, Y
      N-Benzylimidazole for preparation of S9 fraction with multi-induction of metabolizing enzymes in short-term genotoxicity assays

      MUTAGENESIS
    21. Beken, S; De Smet, K; Depreter, M; Roels, F; Vercruysse, A; Rogiers, V
      Effects of L-proline on phase I and phase II xenobiotic biotransformation capacities of rat and human hepatocytes in long-term collagen gel cultures

      ATLA-ALTERNATIVES TO LABORATORY ANIMALS
    22. Kumar, GN; Surapaneni, S
      Role of drug metabolism in drug discovery and development

      MEDICINAL RESEARCH REVIEWS
    23. Schwarz, D; Kisselev, P; Cascorbi, I; Schunck, WH; Roots, I
      Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants

      CARCINOGENESIS
    24. Prueksaritanont, T; Vega, JM; Zhao, J; Gagliano, K; Kuznetsova, O; Musser, B; Amin, RD; Liu, L; Roadcap, BA; Dilzer, S; Lasseter, KC; Rogers, JD
      Interactions between simvastatin and troglitazone or pioglitazone in healthy subjects

      JOURNAL OF CLINICAL PHARMACOLOGY
    25. Vakharia, DD; Liu, N; Pause, R; Fasco, M; Bessette, E; Zhang, QY; Kaminsky, LS
      Polycyclic aromatic hydrocarbon/metal mixtures: Effect on PAH induction ofCYP1A1 in human HEPG2 cells

      DRUG METABOLISM AND DISPOSITION
    26. Schaber, G; Wiatr, G; Wachsmuth, H; Dachtler, M; Albert, K; Gaertner, I; Breyer-Pfaff, U
      Isolation and identification of clozapine metabolites in patient urine

      DRUG METABOLISM AND DISPOSITION
    27. Walles, M; Thum, T; Levsen, K; Borlak, J
      Verapamil metabolism in distinct regions of the heart and in cultures of cardiomyocytes of adult rats

      DRUG METABOLISM AND DISPOSITION
    28. Yu, LJ; Matias, J; Scudiero, DA; Hite, KM; Monks, A; Sausville, EA; Waxman, DJ
      P450 enzyme expression patterns in the NCI human tumor cell line panel

      DRUG METABOLISM AND DISPOSITION
    29. El-Sankary, W; Gibson, GG; Ayrton, A; Plant, N
      Use of a reporter gene assay to predict and rank the potency and efficacy of CYP3A4 inducers

      DRUG METABOLISM AND DISPOSITION
    30. Snyder, MJ; Girvetz, E; Mulder, EP
      Induction of marine mollusc stress proteins by chemical or physical stress

      ARCHIVES OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY
    31. Furuta, S; Kamada, E; Suzuki, T; Sugimoto, T; Kawabata, Y; Shinozaki, Y; Sano, H
      Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole

      XENOBIOTICA
    32. Vakharia, DD; Liu, N; Pause, R; Fasco, M; Bessette, E; Zhang, QY; Kaminsky, LS
      Effect of metals on polycyclic aromatic hydrocarbon induction of CYP1A1 and CYP1A2 in human hepatocyte cultures

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    33. Gierl, A; Frey, M
      Evolution of benzoxazinone biosynthesis and indole production in maize

      PLANTA
    34. Simard, C; O'Hara, GE; Prevost, J; Guilbaud, R; Masse, R; Turgeon, J
      Study of the drug-drug interaction between simvastatin and cisapride in man

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    35. Dandara, C; Masimirembwa, CM; Magimba, A; Sayi, J; Kaaya, S; Sommers, DK; Snyman, JR; Hasler, JA
      Genetic polymorphism of CYP2D6 and CYP2C19 in East- and Southern African populations including psychiatric patients

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    36. Frisbee, JC; Krishna, UM; Falck, JR; Lombard, JH
      Role of prostanoids and 20-HETE in mediating oxygen-induced constriction of skeletal muscle resistance arteries

      MICROVASCULAR RESEARCH
    37. Chang, TKH; Chen, J; Lee, WBK
      Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: Evidence for mechanism-based inactivation of CYP1A2

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    38. Baron, JM; Goh, LB; Yao, DG; Wolf, CR; Friedberg, T
      Modulation of P450CYP3A4-dependent metabolism by P-glycoprotein: Implications for P450 phenotyping

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    39. Downs, CA; Dillon, RT; Fauth, JE; Woodley, CM
      A molecular biomarker system for assessing the health of gastropods (Ilyanassa obsoleta) exposed to natural and anthropogenic stressors

      JOURNAL OF EXPERIMENTAL MARINE BIOLOGY AND ECOLOGY
    40. Hedstrand, H; Ekwall, O; Olsson, MJ; Landgren, E; Kemp, EH; Weetman, AP; Perheentupa, J; Husebye, E; Gustafsson, J; Betterle, C; Kampe, O; Rorsman, F
      The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I

      JOURNAL OF BIOLOGICAL CHEMISTRY
    41. Benes, M; Hudecek, J; Anzenbacher, P; Hof, M
      Coumarin 6, hypericin, resorufins, and flavins: Suitable chromophores for fluorescence correlation spectroscopy of biological molecules

      COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS
    42. Madsen, H; Enggaard, TP; Hansen, LL; Klitgaard, NA; Brosen, K
      Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    43. Oyama, M; Ikeda, T; Lim, TK; Ikebukuro, K; Masuda, Y; Karube, I
      Detection of toxic chemicals with high sensitivity by measuring the quantity of induced p450 mRNAs based on surface plasmon resonance

      BIOTECHNOLOGY AND BIOENGINEERING
    44. Klotz, U; Sailer, D
      Drug interactions - their impact on safe drug therapy as exemplified by the novel group of thiazolidinediones (glitazones)

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    45. Wust, M; Little, DB; Schalk, M; Croteau, R
      Hydroxylation of limonene enantiomers and analogs by recombinant (-)-limonene 3- and 6-hydroxylases from mint (Mentha) species: Evidence for catalysis within sterically constrained active sites

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    46. Betterle, C; Dal Pra, C; Greggio, N; Volpato, M; Zanchetta, R
      Autoimmunity in isolated Addison's disease and in polyglandular autoimmunediseases type 1, 2 and 4

      ANNALES D ENDOCRINOLOGIE
    47. Pirmohamed, M; Park, BK
      Genetic susceptibility to adverse drug reactions

      TRENDS IN PHARMACOLOGICAL SCIENCES
    48. Meisel, C; Roots, I; Cascorbi, I; Brinkmann, U; Brockmoller, J
      How to manage individualized drug therapy: Application of pharmacogenetic knowledge of drug metabolism and transport

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    49. Stefanovic, M; Topic, E; Ivanisevic, AM; Relja, M; Korsic, M
      Genotyping of CYP2D6 in Parkinson's disease

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    50. Ereshefsky, L; Dugan, D
      Review of the pharmacokinetics, pharmacogenetics, and drug interaction potential of antidepressants: Focus on venlafaxine

      DEPRESSION AND ANXIETY
    51. Hugen, PWH; Burger, DM; Brinkman, K; ter Hofstede, HJM; Schuurman, R; Koopmans, PP; Hekster, YA
      Carbamazepine-indinavir interaction causes antiretroviral therapy failure

      ANNALS OF PHARMACOTHERAPY
    52. Crespi, CL; Stresser, DM
      Fluorometric screening for metabolism-based drug-drug interactions

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    53. Peterson, P; Uibo, R; Krohn, KJE
      Adrenal autoimmunity: Results and developments

      TRENDS IN ENDOCRINOLOGY AND METABOLISM
    54. Sinnett, D; Krajinovic, M; Labuda, D
      Genetic susceptibility to childhood acute lymphoblastic leukemia

      LEUKEMIA & LYMPHOMA
    55. Shear, N; Drake, L; Gupta, AK; Lambert, J; Yaniv, R
      The implications and management of drug interactions with itraconazole, fluconazole and terbinafine

      DERMATOLOGY
    56. Katakam, PVG; Hoenig, M; Ujhelyi, MR; Miller, AW
      Cytochrome P450 activity and endothelial dysfunction in insulin resistance

      JOURNAL OF VASCULAR RESEARCH
    57. Aitchison, KJ; Gonzalez, FJ; Quattrochi, LC; Sapone, A; Zhao, JH; Zaher, H; Elizondo, G; Bryant, C; Munro, J; Collier, DA; Makoff, AJ; Kerwin, RW
      Identification of novel polymorphisms in the 5 ' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significance

      PHARMACOGENETICS
    58. Infante-Rivard, C; Krajinovic, M; Labuda, D; Sinnett, D
      Parental smoking, CYP1A1 genetic polymorphisms and childhood leukemia (Quebec, Canada)

      CANCER CAUSES & CONTROL
    59. Simpson, CD; Wu, MT; Christiani, DC; Santella, RM; Carmella, SG; Hecht, SS
      Determination of r-7,t-8,9,c-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene in human urine by gas chromatography/negative ion chemical ionization/mass spectrometry

      CHEMICAL RESEARCH IN TOXICOLOGY
    60. Perniola, R; Falorni, A; Clemente, MG; Forini, F; Accogli, E; Lobreglio, G
      Organ-specific and non-organ-specific autoantibodies in children and youngadults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy(APECED)

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    61. Silva, RD; Kater, CE; Dib, SA; Laureti, S; Forini, F; Cosentino, A; Falorni, A
      Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side-chain cleavage and 17 alpha-hydroxylase in Addison's disease and autoimmune polyendocrine syndrome type III

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    62. Kaye, CM; Nicholls, B
      Clinical pharmacokinetics of ropinirole

      CLINICAL PHARMACOKINETICS
    63. Venkatakrishnan, K; von Moltke, LL; Greenblatt, DJ
      Effects of the antifungal agents on oxidative drug metabolism - Clinical relevance

      CLINICAL PHARMACOKINETICS
    64. Wilcox, RA; Owen, H
      Variable cytochrome P450 2D6 expression and metabolism of codeine and other opioid prodrugs: Implications for the Australian anaesthetist

      ANAESTHESIA AND INTENSIVE CARE
    65. Bonate, PL; Kroboth, PD; Smith, RB; Suarez, E; Oo, C
      Clonazepam and sertraline: Absence of drug interaction in a multiple-dose study

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    66. Poolsup, N; Po, ALW; Knight, TL
      Pharmacogenetics and psychopharmacotherapy

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    67. Maiorova, OA; Zeeger, K; Rumyantsev, AG
      Genetic polymorphism of enzymes involved in drug metabolism and its role in carcinogenesis

      GEMATOLOGIYA I TRANSFUZIOLOGIYA
    68. Cichon, S; Nothen, MM; Rietschel, M; Propping, P
      Pharmacogenetics of schizophrenia

      AMERICAN JOURNAL OF MEDICAL GENETICS
    69. Rojas, M; Cascorbi, I; Alexandrov, K; Kriek, E; Auburtin, G; Mayer, L; Kopp-Schneider, A; Roots, I; Bartsch, H
      Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism

      CARCINOGENESIS
    70. Nicolas, JM
      The metabolic profile of second-generation antihistamines

      ALLERGY
    71. Wynalda, MA; Hauer, MJ; Wienkers, LC
      Oxidation of the novel oxazolidinone antibiotic linezolid in human liver microsomes

      DRUG METABOLISM AND DISPOSITION
    72. Schulz-Utermoehl, T; Edwards, RJ; Boobis, AR
      Affinity and potency of proinhibitory antipeptide antibodies against CYP2D6 is enhanced using cyclic peptides as immunogens

      DRUG METABOLISM AND DISPOSITION
    73. Panesar, NS; Chan, KW
      Decreased steroid hormone synthesis from inorganic nitrite and nitrate: Studies in vitro and in vivo

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    74. Josyula, S; Lu, LJW; Salazar, JJ; Nerurkar, PV; Jones, AB; Grady, JJ; Snyderwine, EG; Anderson, LM
      DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in fetal tissues of patas monkeys after transplacental exposure

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    75. Morel, Y; Coumoul, X; Nalpas, A; Barouki, R
      Nuclear factor I/CCAAT box transcription factor trans-activating domain isa negative sensor of cellular stress

      MOLECULAR PHARMACOLOGY
    76. Morel, Y; De Waziers, I; Barouki, R
      A repressive cross-regulation between catalytic and promoter activities ofthe CYP1A1 and CYP2E1 genes: role of H2O2

      MOLECULAR PHARMACOLOGY
    77. Reimand, K; Peterson, P; Hyoty, H; Uibo, R; Cooke, I; Weetman, AP; Krohn, KJE
      3 beta-hydroxysteroid dehydrogenase autoantibodies are rare in premature ovarian failure

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    78. Soderbergh, A; Rorsman, F; Halonen, M; Ekwall, O; Bjorses, P; Kampe, O; Husebye, ES
      Autoantibodies against aromatic L-amino acid decarboxylase identifies a subgroup of patients with Addison's disease

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    79. Magagnotti, C; Orsi, F; Bagnati, R; Celli, N; Rotilio, D; Fanelli, R; Airoldi, L
      Effect of diet on serum albumin and hemoglobin adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in humans

      INTERNATIONAL JOURNAL OF CANCER
    80. Jounaidi, Y; Waxman, DJ
      Combination of the bioreductive drug tirapazamine with the chemotherapeutic prodrug cyclophosphamide for P450/P450-reductase-based cancer gene therapy

      CANCER RESEARCH
    81. Lim, TK; Oyama, M; Ikebukuro, K; Karube, I
      Detection of atrazine based on the SPR determination of P450 mRNA levels in Saccharomyces cerevisiae

      ANALYTICAL CHEMISTRY
    82. Dettling, M; Sachse, C; Brockmoller, J; Schley, J; Muller-Oerlinghausen, B; Pickersgill, I; Rolfs, A; Schaub, RT; Schmider, J
      Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatients

      PSYCHOPHARMACOLOGY
    83. Feldweg, AM; Leddy, JP
      Drug interactions affecting the efficacy of corticosteroid therapy - A brief review with an illustrative case

      JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
    84. Piquette, RK
      Torsade de pointes induced by cisapride/clarithromycin interaction

      ANNALS OF PHARMACOTHERAPY
    85. Schulz-Utermoehl, T; Bennett, AJ; Ellis, SW; Tucker, GT; Boobis, AR; Edwards, RJ
      Polymorphic debrisoquine 4-hydroxylase activity in the rat is due to differences in CYP2D2 expression

      PHARMACOGENETICS
    86. Wiela-Hojenska, A; Orzechowska-Juzwenko, K; Usnarska-Zubkiewicz, L; Kotlarek-Haus, S; Hurkacz, M
      Phenazone as a marker of liver-metabolic function in patients with acute leukemia

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    87. Raunio, H; Hakkola, J; Hukkanen, J; Lassila, A; Paivarinta, K; Pelkonen, O; Anttila, S; Piipari, R; Boobis, A; Edwards, RJ
      Expression of xenobiotic-metabolizing CYPs in human pulmonary tissue

      EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
    88. Prior, TI; Chue, PS; Tibbo, P; Baker, GB
      Drug metabolism and atypical antipsychotics

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    89. Aaltonen, J; Bjorses, P
      Cloning of the APECED gene provides new insight into human autoimmunity

      ANNALS OF MEDICINE
    90. Ekins, S; Wrighton, SA
      The role of CYP2B6 in human xenobiotic metabolism

      DRUG METABOLISM REVIEWS
    91. Yamazaki, H; Inoue, K; Hashimoto, M; Shimada, T
      Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes

      ARCHIVES OF TOXICOLOGY
    92. Melikian, AA; Sun, P; Prokopczyk, B; El-Bayoumy, K; Hoffmann, D; Wang, X; Waggoner, S
      Identification of benzo[a]pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography-mass spectrometry

      CANCER LETTERS
    93. Hamelin, BA; Dorson, PG; Pabis, D; Still, D; Bouchard, RH; Pourcher, E; Rail, J; Turgeon, J; Crismon, ML
      CYP2D6 mutations and therapeutic outcome in schizophrenic patients

      PHARMACOTHERAPY
    94. Chouinard, G; Lefko-Singh, K; Teboul, E
      Metabolism of anxiolytics and hypnotics: Benzodiazepines, buspirone, zoplicone, and zolpidem

      CELLULAR AND MOLECULAR NEUROBIOLOGY
    95. Baker, GB
      Special issue: Drug metabolism and psychiatry: Part I of II - Preface

      CELLULAR AND MOLECULAR NEUROBIOLOGY
    96. Baker, GB; Urichuk, LJ; McKenna, KF; Kennedy, SH
      Metabolism of monoamine oxidase inhibitors

      CELLULAR AND MOLECULAR NEUROBIOLOGY
    97. Strain, JJ; Caliendo, G; Alexis, JD; Lowe, RS; Karim, A; Loigman, M
      PART II: Cardiac drug and psychotropic drug interactions: Significance andrecommendations

      GENERAL HOSPITAL PSYCHIATRY
    98. Harris, RZ; Inglis, AML; Miller, AK; Thompson, KA; Finnerty, D; Patterson, S; Jorkasky, DK; Freed, MI
      Rosiglitazone has no clinically significant effect on nifedipine pharmacokinetics

      JOURNAL OF CLINICAL PHARMACOLOGY
    99. Nakajima, M; Kobayashi, K; Oshima, K; Shimada, N; Tokudome, S; Chiba, K; Yokoi, T
      Activation of phenacetin O-deethylase activity by alpha-naphthoflavone in human liver microsomes

      XENOBIOTICA
    100. Hemeryck, A; De Vriendt, C; Belpaire, FM
      Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: in vitro studies with tolbutamide and (S)-warfarin using human liver microsomes

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 02:29:20